ELI LILLY & Co — Director's Dealing 2015

Nov 16, 2015

SEC Form 4/A — Form 4/A

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2015-11-05

Reporting Person: Ricks David A (SVP and Pres, Lilly Bio-Meds)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-05	Common Stock	F	3908	$81.05	Disposed	61200	Direct

Footnotes

F1: This amendment is being filed to correctly report the amount disposed in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5.